2014
DOI: 10.1007/s11999-013-3438-0
|View full text |Cite
|
Sign up to set email alerts
|

Novel Microhydroxyapatite Particles in a Collagen Scaffold: A Bioactive Bone Void Filler?

Abstract: The collagen-glycosaminoglycan scaffold may be suitable for a low load-bearing defect. The collagen-hydroxyapatite scaffold may be suitable for a load-bearing defect. The rhBMP-2 containing collagen-glycosaminoglycan and collagen-hydroxyapatite scaffolds may be suitable for established nonunion defects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
70
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 82 publications
(71 citation statements)
references
References 3 publications
1
70
0
Order By: Relevance
“…57 However, concerns remain about the resultant secondary wound site, supply and disease transmission, as well as the need for shaping of donor bone to fit often complex defects. With world demand topping two million bone replacement procedures per year, 8, 9 tissue engineering approaches offer the tantalizing possibility of generating a mechanically robust, patient-customized implant to enhance bone regeneration. However, the development of appropriate biomaterial substrates requires balancing structural, mechanical, and biomolecular design concerns as well as considering the appropriate selection of clinically-relevant cell populations.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…57 However, concerns remain about the resultant secondary wound site, supply and disease transmission, as well as the need for shaping of donor bone to fit often complex defects. With world demand topping two million bone replacement procedures per year, 8, 9 tissue engineering approaches offer the tantalizing possibility of generating a mechanically robust, patient-customized implant to enhance bone regeneration. However, the development of appropriate biomaterial substrates requires balancing structural, mechanical, and biomolecular design concerns as well as considering the appropriate selection of clinically-relevant cell populations.…”
Section: Introductionmentioning
confidence: 99%
“…9, 1820 Such biomaterial substrates offer the advantages of tunability , namely allowing the manipulation of biomaterial morphology, such as fiber alignment; 21 topology, like surface roughness; 22 and substrate stiffness. 23, 24 However, the inclusion of growth factors such as BMP-2 or BMP-7 (known commercially as OP-1) 25, 26 or full-biochemical supplementation strategies such as osteogenic media 14, 2729 remain a common, if not ubiquitous, practice of soluble supplementation.…”
Section: Introductionmentioning
confidence: 99%
“…1, 35, 54 Carbodiimide crosslinking represent a common approach to tether biomolecules to a biomaterial surface, as well as to crosslinking collagen-based biomaterials. 22, 39, 55 In the context of crosslinking collagen-based scaffolds, previous efforts have examined the use of bulk versus step crosslinking, the impact of changing the EDC:NHS ratio, and the reaction pH.…”
Section: Discussionmentioning
confidence: 99%
“…Good applied science draws a straight line from the laboratory to the practice of orthopaedic surgery, and so has some immediate clinical relevance. Recent examples in CORR 1 might include the studies by Elkins's group [2] and that of Lyons et al [4], although the latter emphasizes that drawing a sharp distinction between basic and applied research sometimes is difficult. By contrast, we are much less interested in studies whose answers can be predicted in advance based on wellestablished fundamental principles.…”
Section: F Rom the First Days Of Clinicalmentioning
confidence: 99%